ASSOCIATIONS BETWEEN EXERCISE PATTERNS AND CLINICAL OUTCOMES IN A PROSPECTIVE COHORT OF PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE

被引：0
|
作者：
Czapla, Blake
Dalvi, Anushka
Chen, Vincent L.
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1532
引用
收藏
页码：S1627 / S1627
页数：1
相关论文
共 50 条
  • [21] Waitlist and transplant outcomes in patients with metabolic dysfunction-associated steatotic liver disease and autoimmune hepatitis
    Medina-Morales, Esli
    Ismail, Mohamed
    Goyal, Ritik M.
    Marenco-Flores, Ana
    Saberi, Behnam
    Fricker, Zachary
    Bonder, Alan
    Trivedi, Hirsh D.
    LIVER INTERNATIONAL, 2024, 44 (11) : 3083 - 3095
  • [22] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
  • [23] Socioeconomic factors associated with the presence of and outcomes in metabolic dysfunction-associated steatotic liver disease
    Nasr, Patrik
    Shang, Ying
    Wester, Axel
    Strandberg, Rickard
    Widman, Linnea
    Lazarus, Jeffrey V.
    Hagstrom, Hannes
    LIVER INTERNATIONAL, 2024, 44 (11) : 3050 - 3059
  • [24] The Associations between Healthy Eating Patterns and Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Case-Control Study
    Huang, Xia
    Gan, Da
    Fan, Yahui
    Fu, Qihui
    He, Cong
    Liu, Wenjian
    Li, Feng
    Ma, Le
    Wang, Mingxu
    Zhang, Wei
    NUTRIENTS, 2024, 16 (12)
  • [25] Visceral Fat and Diabetes: Associations With Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Kumar, Ashish
    Arora, Anil
    Sharma, Praveen
    Jan, Shayesta
    Ara, Ishrat
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2025, 15 (01)
  • [26] Creatinine as a predictor of clinical events in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Di Betto, G.
    Farina, A.
    Palumbo, P.
    Patrizi, B.
    Righetti, R.
    Ferrarini, S.
    Corradini, E.
    Pietrangelo, A.
    Buzzetti, E.
    DIGESTIVE AND LIVER DISEASE, 2025, 57 : S37 - S38
  • [27] Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease
    Suzuki, Keito
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Takahashi, Yuka
    Yamazaki, Yudai
    Uchihara, Naoki
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada, Michiko
    Keitoku, Taisei
    Okada, Risa
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2024, 54 (06) : 600 - 605
  • [28] Systematic review of exercise for the treatment of pediatric metabolic dysfunction-associated steatotic liver disease
    Smith, Martha R.
    Yu, Elizabeth L.
    Malki, Ghattas J.
    Newton, Kimberly P.
    Goyal, Nidhi P.
    Heskett, Karen M.
    Schwimmer, Jeffrey B.
    PLOS ONE, 2024, 19 (12):
  • [29] Metabolic signatures of metabolic dysfunction-associated steatotic liver disease in severely obese patients
    Babu, Ambrin Farizah
    Palomurto, Saana
    Karja, Vesa
    Kakela, Pirjo
    Lehtonen, Marko
    Hanhineva, Kati
    Pihlajamaki, Jussi
    Mannisto, Ville
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (12) : 2103 - 2110
  • [30] Cross talk between the liver microbiome and epigenome in patients with metabolic dysfunction-associated steatotic liver disease
    Pirola, Carlos Jose
    Salatino, Adrian
    Gianotti, Tomas Fernandez
    Castano, Gustavo Osvaldo
    Garaycoechea, Martin
    Sookoian, Silvia
    EBIOMEDICINE, 2024, 101
12345